Neoral versus Sandimmune in kidney transplantation.
Tisone
G
G
Università di Roma Tor Vergata, Clinica Chirurgica, Centro Trapianti, Ospedale S. Eugenio, Roma, Italy.
Orlando
G
G
Mercadante
E
E
Vennarecci
G
G
Pisani
F
F
Buonomo
O
O
Negrini
S
S
Casciani
C U
CU
D000284:Administration, Oral; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone